Conditions: Other Osteoporosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 285
Healthy volunteers: no

Brief summary:
Two year study to determine the safety and efficacy of weekly 35 mg Risedronate doses in men with osteoporosis followed by a two year follow-up study.

Detailed description:

Arms:
arm 1: Placebo tablet once a week for 2 years followed by once a week Risedronate for 2 years arm 2: 35 mg risedronate tablet once a week for 2 years followed by open label 35 mg risedronate once a week for 2 years

Interventions: intervention 1: Placebo tablet intervention 2: Risedronate
Intervention descriptions: intervention 1: one placebo once a week for two years followed by one 35 mg risedronate once a week for two years intervention 2: one 35 mg risedronate once a week for two years followed by one 35 mg risedronate once a week for two years

Protocol document: